ClinicalTrials.Veeva

Menu

RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi (RTSS/PBO)

Michigan State University logo

Michigan State University

Status

Unknown

Conditions

Malaria, Malaria Vaccine, Insecticide-treated Bednets

Treatments

Biological: RTS,S/AS01 malaria vaccine
Other: PBO bed nets

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT04327440
3U19AI089683-10S1 (U.S. NIH Grant/Contract)
00002662

Details and patient eligibility

About

The overall goal of this study is to assess the impact of RTS,S (malaria) vaccination and PBO nets on malaria infection and transmission, independently and how they interact when they are introduced together.

The specific objectives for the study are as follows:

  1. To estimate the impact of PBO nets and RTS,S vaccine on Plasmodium infection prevalence and transmission, independently and how they interact when they are introduced together in Malawi (Phase 1).
  2. To assess the feasibility of evaluating the impact of RTS,S vaccine and PBO nets independently in a larger scale future study.

Full description

Introduction: The decline in malaria incidence has stalled globally and incidence is increasing in some high transmission settings of sub-Saharan Africa, including Malawi. The situation is worsening despite the scale-up of previously effective interventions, raising concerns that the impact of current malaria control and prevention strategies maybe compromised.

Problem: There is an urgent need for innovative approaches to malaria control and Malawi is currently positioned to assess two of the most promising new interventions. The Malawi Ministry of Health (MOH) is launching large scale projects to evaluate a new formulation of insecticide-treated bed nets with a chemical synergist, piperonyl butoxide (PBO), designed to enhance the insecticidal effect of pyrethroids and the new malaria vaccine RTS,S (RTS,S). In an effort to gain the most information from these, interventions Malawi's National Malaria Control Programme (NMCP) have invited the Malawi International Center for Excellence in Malaria Research (ICEMR) to evaluate the effectiveness of the two interventions (alone and in combination) on malaria prevalence and transmission.

Objective: In this proposed implementation study, we propose to assess the impact of PBO nets and RTS,S vaccine on Plasmodium infection prevalence and transmission.

Study type and methodology: We will enroll children in a prospective cohort study in which the follow-up will be at the 2nd, 4th, and 6th month. We are selecting two health center catchment areas: one in which both RTS,S and PBO nets are available through the government health system and one in which there is no RTS,S vaccine available and standard long-lasting insecticide-treated nets (LLINS) have been distributed through the public section. At each visit, we will collect specimens to identify malaria infection and detect gametocyte infections. We will also collect and analyze mosquitoes from 100 households in both catchment areas to provide an entomological evidence of the force of infection. Children in households that are scheduled to receive both PBO nets and RTS,S vaccine will be compared to children in households that are not scheduled to receive either of these interventions.

Enrollment

3,000 estimated patients

Sex

All

Ages

7 months to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children aged 7 to 18 months of age (age-eligible for at least 3 doses of RTS,S doses) OR being one of not more than two children living in the household of an enrolled age-eligible child and being >18 mos and < 10 years of age.
  • Not on cotrimoxazole prophylaxis for HIV infection
  • Weight >5 kg
  • Permanent residence of Health Centre (HC) catchment area
  • Residence within 10 km from the HC
  • Written informed consent from parent/guardian for the child to participate in the study

Exclusion criteria

Non-residents of the catchment area and visitors to the study area will be excluded because the study requires follow-up for at least 6 months and access to interventions such as conventional, PBO nets and malaria vaccination.

Trial design

3,000 participants in 4 patient groups

Nyambi, rainy season
Description:
250 children of age-eligible for RTS,S vaccine (7-18 months) 500 siblings (\>18 months, \< 10 years of age) The duration of the cohort is six months.
Treatment:
Other: PBO bed nets
Biological: RTS,S/AS01 malaria vaccine
Nyambi, dry season
Description:
250 children of age-eligible for RTS,S vaccine (7-18 months) 500 siblings (\>18 months, \< 10 years of age) The duration of the cohort is six months.
Treatment:
Other: PBO bed nets
Biological: RTS,S/AS01 malaria vaccine
Kalembo, rainy season
Description:
250 children of age-eligible for RTS,S vaccine (7-18 months) 500 siblings (\>18 months, \< 10 years of age) The duration of the cohort is six months.
Kalembo, dry season
Description:
250 children of age-eligible for RTS,S vaccine (7-18 months) 500 siblings (\>18 months, \< 10 years of age) The duration of the cohort is six months.

Trial contacts and locations

1

Loading...

Central trial contact

Terrie E Taylor, D.O.; Edward N. Walker, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems